

Author: Netter Hans-Jüürgen Chang Shau-Feng Bruns Michael
Publisher: Future Medicine
ISSN: 1746-0794
Source: Future Virology, Vol.3, Iss.1, 2008-01, pp. : 83-94
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Nuclear factor kappa B and hepatitis viruses
By Guan Yong-Song He Qing Wang Ming-Quan Li Ping
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. :


Modeling infection with hepatitis B viruses in vivo
By Dandri Maura Volz Tassilo Lutgehetmann Marc Petersen Jorg
Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. :



